(Q42910090)

11 November 2017

title

Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese (English)

1 reference

genome-wide association study

11 November 2017

main subject

0 references

(RS)-warfarin

1 reference

based on heuristic

inferred from title

single-nucleotide polymorphism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20833655

11 July 2024

4

Michiaki Kubo

1 reference

11 November 2017

3

Atsushi Takahashi

1 reference

11 November 2017

7

Yusuke Nakamura

1 reference

11 November 2017

6

Naoyuki Kamatani

1 reference

11 November 2017

1

Pei-Chieng Cha

1 reference

11 November 2017

5

Shiro Minami

1 reference

11 November 2017

Taisei Mushiroda

2

1 reference

11 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20833655

11 July 2024

publication date

10 September 2010

1 reference

full work available at URL

11 November 2017

http://hmg.oxfordjournals.org/content/early/2010/09/10/hmg.ddq389.full.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20833655

http://hmg.oxfordjournals.org/cgi/content/abstract/19/23/4735

11 July 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20833655

http://academic.oup.com/hmg/article-pdf/19/23/4735/17249860/ddq389.pdf

11 July 2024

file format

Portable Document Format

1 reference

11 July 2024

published in

Human Molecular Genetics

1 reference

11 November 2017

volume

19

1 reference

11 November 2017

issue

23

1 reference

11 November 2017

page(s)

4735-4744

1 reference

describes a project that uses

11 November 2017

genome-wide association study

1 reference

based on heuristic

inferred from title

cites work

The critical path of warfarin dosing: finding an optimal dosing strategy using pharmacogenetics

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Warfarin therapy: influence of pharmacogenetic and environmental factors on the anticoagulant response to warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Medication use leading to emergency department visits for adverse drug events in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Effect of ageing upon warfarin dose requirements: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Racial background is a determinant of average warfarin dose required to maintain the INR between 2.0 and 3.0.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Common VKORC1 and GGCX polymorphisms associated with warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Pharmacogenetics of warfarin: development of a dosing algorithm for brazilian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Genetic determinants of warfarin dosing in the Han-Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Genetic and clinical predictors of warfarin dose requirements in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Estimation of the warfarin dose with clinical and pharmacogenetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Pharmacogenetics of warfarin: current status and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Association of warfarin dose with genes involved in its action and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Warfarin dose related to apolipoprotein E (APOE) genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Apolipoprotein E (APOE) and warfarin dosing in an Italian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Evaluation of genetic factors for warfarin dose prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

The largest prospective warfarin-treated cohort supports genetic forecasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

CYP4F2 genetic variant alters required warfarin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

A genome-wide association study of acenocoumarol maintenance dosage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Clinical consequences of cytochrome P450 2C9 polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

A high-throughput SNP typing system for genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

PLINK: a tool set for whole-genome association and population-based linkage analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

WGAViewer: software for genomic annotation of whole genome association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2FDDQ389

Warfarin: an old drug but still interesting

21 January 2018

1

1 reference

Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans

11 July 2024

7

1 reference

Annals of Internal Medicine

11 July 2024

9

165

1095

2004

1 reference

The Pharmacogenomics Journal

11 July 2024

26

8

53

2007

1 reference

The mechanism of the interaction between amiodarone and warfarin in humans

11 July 2024

37

1 reference

Genetic variation in metabolizing enzyme and transporter genes: comprehensive assessment in 3 major East Asian subpopulations with comparison to Caucasians and Africans

11 July 2024

39

1 reference

11 July 2024

Identifiers

DOI

10.1093/HMG/DDQ389

1 reference

11 November 2017

1 reference